EARLYDIAGNOSTICS INC
Los Angeles, CA · Medtech · Private
Blood-based cell-free DNA methylation profiling test (MethylScan) for early cancer detection and tumor localization
earlydx.com →- Grants
- $4.3M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $2.4M
- 2 awards · Health and Human S
- #193 of 4531 in medtech
- Patents
- 12
- 0 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · An Accurate, Non-invasive, and Cost-effective Methylome Test for Early Cancer Detection | $351,646 | |
| Federal contract | Department of Health and Human Services · Topic 428 "cloud-based Liquid-biopsy Platform For The Cancer Research Data Commons" | $395,918 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · MethylScan for Early Detection of Liver and Lung Cancer | $997,285 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · MethylScan for Early Detection of Liver and Lung Cancer | $1,994,570 | |
| Federal contract | Department of Health and Human Services · Topic 428 - Nci SBIR Transition To Phase II Solicitation Fy 2023 | $1,994,911 | |
| Federal grant | Department of Health and Human Services · Phase II · MethylScan for Early Detection of Liver and Lung Cancer | $997,285 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 190 | PORTABLE DIAGNOSTIC SYSTEMS INC | $2.4M | — |
| 191 | AVONEAUX MEDICAL INSTITUTE, LLC | $2.4M | — |
| 192 | TETRAIMAGING LLC | $2.4M | — |
| 193 | EARLYDIAGNOSTICS INC | $2.4M | — |
| 194 | SPATIAL SURGICAL LLC | $2.4M | — |
| 195 | BOSTON CELL STANDARDS INC. | $2.4M | — |
| 196 | EMITECH, INC. | $2.4M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Library Preparation To Enrich Informative Dna Fragments Using Enzymatic Digestionapplication
- Sensitively Detecting Copy Number Variations (cnvs) From Circulating Cell-free Nucleic Acidapplication
- Methods Of Methylation Analysis For Disease Detectionapplication
- Methods Of Methylation Analysis For Disease Detectionapplication
- Methods Of Methylation Analysis For Disease Detectionapplication
- Methods For Library Preparation To Enrich Informative Dna Fragments Using Enzymatic Digestionapplication
- Methods And Systems For Sequencing Cell-free Microbiome Dnaapplication
- Sensitively Detecting Copy Number Variations (cnvs) From Circulating Cell-free Nucleic Acidapplication
- Methods For Library Preparation To Enrich Informative Dna Fragments Using Enzymatic Digestionapplication
- Methods Of Hyper- And Hypo-methylation Analysis For Disease Detectionapplication
- Methods For The Effective Sequencing Of Cell-free Microbiome Dnaapplication
- Methods Of Hyper- And Hypo-methylation Analysis For Disease Detectionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.